Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Daniel M Hartung

Datos Biográficos

ID5543129
NOMBREDaniel M Hartung
NOMBRESDaniel M
APELLIDOHartung
FIRMAHARTUNG D M
AFILIACIONESOregon State University
ORCID0000-0002-0685-773X
VERIFICADOSí
TOTAL DE OBRAS5
TOTAL DE CITAS0
TOTAL COMO AUTOR5
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2008
AÑO MÁS RECIENTE DE PUBLICACIÓN2024
ÍNDICE H0
  • Changes in Buprenorphine Prescribing in Community Health Centers

    Open Access•Daniel M Hartung, Robert Voss et al.•ARTICLE•JAMA Health Forum•2024

    This cohort study characterizes changes in buprenorphine prescribing among community health center clinicians between 2016 and 2021

  • The Geographic Impact of Buprenorphine Expansion to Nurse Practitioner Prescribers in Oregon

    Open Access•Tracy Klein, Jonah Geddes et al.•ARTICLE•The Journal of Rural Health•2022

    PURPOSE: We examined the impact on geographic distribution of medications to treat opioid use disorder (MOUD) in Oregon after the Comprehensive Addiction and Recovery Act (CARA) was implemented in February 2017 to include nurse practitioner (NP) prescribers. METHODS: We conducted interrupted time series analysis with linear regression on prescriptions dispensed for buprenorphine used for MOUD in the Oregon Prescription Drug Monitoring Database wr…

  • Reducing overdose after release from incarceration (Roar)

    Open Access•Elizabeth Needham Waddell, Robin Baker et al.•ARTICLE•Health & Justice•2020

  • Rural‐Urban Differences in Chronic Disease and Drug Utilization in Older Oregonians

    Open Access•Leah M Goeres, Allison Gille et al.•ARTICLE•The Journal of Rural Health•2016

    PURPOSE: To characterize disease burden and medication usage in rural and urban adults aged ≥85 years. METHODS: This is a secondary analysis of 5 years of longitudinal data starting in the year 2000 from 3 brain-aging studies. Cohorts consisted of community-dwelling adults: 1 rural cohort, the Klamath Exceptional Aging Project (KEAP), was compared to 2 urban cohorts, the Oregon Brain Aging Study (OBAS) and the Dementia Prevention study (DPS). In …

  • Impact of a Medicaid Copayment Policy on Prescription Drug and Health Services Utilization in a Fee-for-Service Medicaid Population

    Daniel M Hartung, Matthew J Carlson et al.•ARTICLE•Medical Care•2008•Referencias: 23

    BACKGROUND: Copayments (copays) for prescription drugs are a common policy among state Medicaid programs. Research exploring the effects of copays on pharmacy and health care utilization in Medicaid patients is limited, especially among patients with chronic disease. OBJECTIVES: The goal of this research was to quantify the impact of a copay policy for prescription drugs on medication and health services utilization overall and among subjects wit…

Sin obras prominentes en esta página.

  • Impact of a Medicaid Copayment Policy on Prescription Drug and Health Services Utilization in a Fee-for-Service Medicaid Population

    Daniel M Hartung, Matthew J Carlson et al.•ARTICLE•Medical Care•2008•Referencias: 23

    BACKGROUND: Copayments (copays) for prescription drugs are a common policy among state Medicaid programs. Research exploring the effects of copays on pharmacy and health care utilization in Medicaid patients is limited, especially among patients with chronic disease. OBJECTIVES: The goal of this research was to quantify the impact of a copay policy for prescription drugs on medication and health services utilization overall and among subjects wit…

  • Rural‐Urban Differences in Chronic Disease and Drug Utilization in Older Oregonians

    Open Access•Leah M Goeres, Allison Gille et al.•ARTICLE•The Journal of Rural Health•2016

    PURPOSE: To characterize disease burden and medication usage in rural and urban adults aged ≥85 years. METHODS: This is a secondary analysis of 5 years of longitudinal data starting in the year 2000 from 3 brain-aging studies. Cohorts consisted of community-dwelling adults: 1 rural cohort, the Klamath Exceptional Aging Project (KEAP), was compared to 2 urban cohorts, the Oregon Brain Aging Study (OBAS) and the Dementia Prevention study (DPS). In …

  • Reducing overdose after release from incarceration (Roar)

    Open Access•Elizabeth Needham Waddell, Robin Baker et al.•ARTICLE•Health & Justice•2020

  • The Geographic Impact of Buprenorphine Expansion to Nurse Practitioner Prescribers in Oregon

    Open Access•Tracy Klein, Jonah Geddes et al.•ARTICLE•The Journal of Rural Health•2022

    PURPOSE: We examined the impact on geographic distribution of medications to treat opioid use disorder (MOUD) in Oregon after the Comprehensive Addiction and Recovery Act (CARA) was implemented in February 2017 to include nurse practitioner (NP) prescribers. METHODS: We conducted interrupted time series analysis with linear regression on prescriptions dispensed for buprenorphine used for MOUD in the Oregon Prescription Drug Monitoring Database wr…

  • Changes in Buprenorphine Prescribing in Community Health Centers

    Open Access•Daniel M Hartung, Robert Voss et al.•ARTICLE•JAMA Health Forum•2024

    This cohort study characterizes changes in buprenorphine prescribing among community health center clinicians between 2016 and 2021

Medicine (5 obras) · Internal Medicine (4 obras) · Environmental health (3 obras) · Family medicine (3 obras) · Opioid (3 obras) · Opioid Use Disorder Treatment (3 obras) · Population (3 obras) · Buprenorphine (2 obras) · Cohort (2 obras) · Cohort study (2 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae